Research Analysts’ updated eps estimates for Monday, August 21st:

Cardiome Pharma Corporation (NASDAQ:CRME) (TSE:COM) was given a $8.00 target price by analysts at Canaccord Genuity. The firm currently has a buy rating on the stock. The analysts wrote, “Date and time of first dissemination: August 21, 2017, 09:42 ET Date and time of production: August 21, 2017, 09:42 ET Target Price / Valuation Methodology: Cardiome Pharma Corp. – CRME Discounted cash flow analysis supports an $8 valuation for CRME shares Our discounted cash flow (DCF) analysis leads us to a 12-month valuation of around $8/share for CRME, assuming continued progress on the Brinavess Canada and Xydalba launches along with a potential Trevyent launch in 2019. We estimate a weighted average cost of capital (WACC) of 11.2%, which assumes an 88% equity/total capital structure at a 10.3% cost of equity capital and a 12% debt/total capital structure at a 14% cost of debt. We use a long-term estimated tax rate of 22% and a terminal growth decline of 1% in our analysis. For cash management purposes, our analysis assumes an equity raise in 2H/17 but management has not publicly commented on the possibility of future capital raises. Risks to achieving Target Price / Valuation: Cardiome Pharma Corp. – CRME OUS payers and providers can be more difficult to predict – Given the relative lack of market data compared to the US coupled with a fragmented payer landscape, variability in physician training and standard of care modalities, and different preferences in patient populations in OUS markets, the marketability of a product in these environments can be more difficult to predict than in the US.””

Earthstone Energy (NASDAQ:ESTE) was given a $16.00 target price by analysts at Roth Capital. The firm currently has a buy rating on the stock.

Foot Locker (NYSE:FL) had its buy rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $50.00 target price on the stock.

Foot Locker (NYSE:FL) had its hold rating reiterated by analysts at FBR & Co. The analysts wrote, “We are reiterating our Buy rating, estimates and $13 price target for 1-800- FLOWERS.COM with the company announcing 4QFY17 (June) results before the open on Thursday. Although 4Q is traditionally an unimportant quarter with virtually no major gifting events, we believe it is important for 1-800-FLOWERS.COM, after a disastrous quarter by direct competitor FTD, to demonstrate it is taking share in floral (as opposed to the segment shrinking); we believe they will register solid floral growth. Further, we remain positive on the potential for upside from the initial FY18 guide, which should register better Holiday results with Harry & David and continued solid floral results.””

1-800 FLOWERS.COM (NASDAQ:FLWS) was given a $13.00 price target by analysts at FBR & Co. The firm currently has a buy rating on the stock.

Guess? (NYSE:GES) was given a $16.00 target price by analysts at FBR & Co. The firm currently has a buy rating on the stock. The analysts wrote, “We are reiterating our Buy rating, estimates, and $16 price target with GUESS? scheduled to announce F2Q18 (July) results after the close on Wednesday, August 23. We believe, once again, that the split between international and domestic operations will be stark, with international remaining strong and the domestic division continuing to fade. Further, with the USD weakening since the last guide, we expect that the potential for upside in 2Q, but more importantly the back half of FY18, will be materially increasing.””

Hibbett Sports (NASDAQ:HIBB) had its neutral rating reaffirmed by analysts at Susquehanna Bancshares Inc. Susquehanna Bancshares Inc currently has a $11.00 target price on the stock, down from their previous target price of $15.00.

Ironwood Pharmaceuticals (NASDAQ:IRWD) was given a $20.00 target price by analysts at Cowen and Company. The firm currently has a buy rating on the stock.

Lincoln Electric Holdings (NASDAQ:LECO) had its buy rating reaffirmed by analysts at FBR & Co.

MAG Silver Corp (NYSE:MAG) was given a $22.00 target price by analysts at Roth Capital. The firm currently has a buy rating on the stock.

ManTech International Corporation (NASDAQ:MANT) had its buy rating reiterated by analysts at Cowen and Company. They currently have a $45.00 target price on the stock. The analysts wrote, “MANT offers ramping sales growth supported by a 1.6x LTM book/bill, a strong.””

Perry Ellis International (NASDAQ:PERY) was given a $25.00 price target by analysts at FBR & Co. The firm currently has a buy rating on the stock. The analysts wrote, “We are reiterating our Buy rating, estimates and $25 price target for PERY with the company reporting 2QFY18 (July) results before the open on Thursday. Given Street worries over the department store sector, PERY is trading within 5% of its 52 week low; as such, we believe expectations are low for 2Q and guidance. That said, we believe the company is set for solid upside to 2Q driven by the rollout of the Nicklaus line, expansion both domestically and internationally by Callaway (ELY) and continued market share gains in department stores, which we believe will offset weakness at JC Penney (JCP) and Kohl’s (KSS).””

PVH Corp. (NYSE:PVH) was given a $135.00 price target by analysts at FBR & Co. The firm currently has a buy rating on the stock. The analysts wrote, “We are reiterating our Buy rating, estimates, and price target of $135 on PVH ahead of what should be a positive 2Q print and ensuing conference call on numerous levels, including domestic market share gains for Calvin Klein and Tommy Hilfiger, strong European and Asian results, and a weakening of the USD, which should all be key positives for PVH. As such, we expect a solid quarter and continued material progress in F2H18.””